Qelbree (viloxazine extendedrelease capsules): Final Results of the Long-Term, Phase 3, Open- Label Extension Trial in Adults with ADHD

Authors
Category Primary study
ConferenceNeuroscience Education Institute Congress, NEI 2023
Year 2024
This article has no abstract
Epistemonikos ID: b1bbaa3c4e25696adf5973dec502c4072e3f64e1
First added on: Apr 19, 2025